Informação sobre produto
COMPOUND 19 is a selective, active analogue of the antimicrobial agent moxifloxacin. COMPOUND 19 has been shown to have inhibitory effects on cancer cells such as MCF-7 and MDA-MB-231, which are associated with breast cancer. In addition, COMPOUND 19 has been shown to be an α7 nicotinic acetylcholine receptor agonist that can induce apoptosis in these cells. It also inhibits the adenosine A3 receptor and mitochondrial membrane potential, which are both important in tumorigenesis. This compound is also effective against infectious diseases such as influenza and HIV. COMPOUND 19 may also be used to treat other types of cancers, including colon cancer and prostate cancer.
Propriedades químicas
Consulta técnica sobre: 3D-BC177726 COMPOUND 19
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
